yjgW Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
yjgW antibody; b4274 antibody; JW4233 antibody; Putative uncharacterized protein YjgW antibody
Target Names
yjgW
Uniprot No.

Q&A

What is the yjgW protein and what makes antibodies against it significant for research?

The yjgW (also referred to as jgw in some literature) is a chimeric protein consisting of two domains - a smaller ynd-derived domain at the amino terminus and a larger Adh-derived domain at the carboxyl terminus. This chimeric structure represents a form of exon shuffling where the Adh coding region was recombined with another domain .

Antibodies against yjgW are valuable for studying protein evolution, functional diversity, and enzyme activity. The JGW protein's unique structure makes it an excellent model for investigating how novel protein functions emerge through domain combinations and natural selection .

How can I rigorously validate the specificity of a yjgW antibody?

Research antibody specificity is a critical concern, with an estimated $1 billion of research funding wasted annually on non-specific antibodies . To comprehensively validate yjgW antibody specificity:

  • Implement knockout (KO) cell line controls as negative references

  • Perform side-by-side testing with other commercially available antibodies targeting the same protein

  • Evaluate performance across multiple applications including immunoblotting, immunoprecipitation, and immunofluorescence

  • Test for cross-reactivity with structurally similar proteins

  • Document batch-to-batch variation through standardized protocols

The Structural Genomics Consortium's YCharOS (Antibody Characterization through Open Science) initiative provides an excellent model for systematic antibody validation .

What experimental conditions affect yjgW antibody binding performance?

Multiple experimental factors can significantly influence antibody binding performance:

  • Sample preparation methods (native vs. denatured conditions)

  • Buffer composition (pH, salt concentration, detergents)

  • Blocking reagents (BSA, milk, commercial blockers)

  • Incubation time and temperature

  • Post-translational modifications of the target protein

  • Exposure of hidden epitopes through conformational changes

For example, research on influenza hemagglutinin antibodies demonstrated that pretreatment of samples at low pH exposing conserved domains was crucial for optimal ELISA performance . Similar considerations may apply to yjgW antibody applications.

How should I design experiments to evaluate epitope specificity of yjgW antibodies?

Epitope characterization is essential for understanding antibody function. Based on approaches used in antibody research:

  • X-ray crystallography of antibody-antigen complexes to determine binding structures

  • Cryo-electron microscopy (cryo-EM) to visualize binding conformations

  • Peptide arrays with overlapping segments to map binding regions

  • Site-directed mutagenesis of potential epitope residues followed by binding assays

  • Competitive binding assays with fragments of the target protein

In influenza antibody research, researchers successfully identified a novel conserved epitope between the receptor-binding pocket and the Ca2 antigenic site through fine mapping techniques . Similar methodological approaches could be applied to yjgW antibody research.

What statistical Design of Experiments (DOE) approach is optimal for yjgW antibody assay development?

An effective DOE approach for antibody assay optimization should consider:

  • Definition of key response variables (signal-to-noise ratio, specificity, sensitivity)

  • Identification of critical experimental factors to evaluate systematically:

FactorLow LevelMid LevelHigh Level
Antibody Concentration0.5 μg/ml2.0 μg/ml5.0 μg/ml
Incubation Time1 hour4 hoursOvernight
Temperature4°CRoom Temp37°C
Buffer pH6.07.48.5
  • Selection of appropriate experimental design (factorial, response surface methodology)

  • Inclusion of scouting experiments to determine appropriate factor ranges

  • Statistical analysis to identify optimal conditions and significant factor interactions

For example, scouting experiments for antibody reagents might investigate the relationship between time, concentration, and response similar to approaches documented in pharmaceutical research .

How can I design an immunological model system to study yjgW antibody responses?

Designing immune models for studying antibody responses requires consideration of multiple components:

  • Selection of appropriate in vitro system:

    • Human cell line-based models

    • Primary cell cultures

    • Co-culture systems with relevant immune components

  • Inclusion of key immune components:

    • Antigen-presenting cells

    • T and B lymphocytes

    • Cytokine networks

  • Readout systems for measuring:

    • Antibody production and specificity

    • Cell-mediated responses

    • Functional consequences of antibody binding

As noted in immunological research methodology, "The adaptive immune system is a complex system structured through a cascade of cells, receptors, and cytokines that process, respond, initiate, memorise, and deliver an immune response or tolerance" . This complexity must be accounted for in experimental design.

How can I reconcile contradictory results from different yjgW antibody-based detection methods?

When faced with contradictory results across different detection platforms:

  • Evaluate the validation status of each antibody in each specific application

  • Consider epitope accessibility differences between methods (native vs. denatured conditions)

  • Assess buffer compatibility issues that might affect antibody binding

  • Determine if post-translational modifications affect detection differently

  • Implement orthogonal, non-antibody methods (e.g., mass spectrometry) to resolve contradictions

  • Test in knockout systems to confirm specificity in each application context

The YCharOS initiative has demonstrated that systematic characterization of antibodies across applications can identify method-specific limitations and resolve apparent contradictions in results .

What approaches can distinguish between genuine yjgW antibody signal and technical artifacts?

To differentiate genuine signals from artifacts:

  • Implement hierarchical controls:

    • Isotype controls to detect non-specific binding

    • Secondary antibody-only controls to identify direct binding issues

    • Knockout or knockdown samples as negative controls

    • Overexpression systems as positive controls

  • Use multiple antibodies targeting different epitopes on yjgW

  • Perform signal validation with orthogonal techniques

  • Implement biological replicates with appropriate statistical analysis

  • Evaluate signal correlation with known biological conditions affecting yjgW expression

What strategies exist for optimizing yjgW antibody performance in challenging samples?

When working with challenging samples:

  • Modify sample preparation to enhance epitope accessibility:

    • Optimize fixation methods for immunohistochemistry

    • Test multiple lysis buffers for protein extraction

    • Consider antigen retrieval methods for fixed tissues

  • Adapt blocking conditions to reduce background:

    • Test different blocking agents (BSA, milk, commercial blockers)

    • Optimize blocking time and temperature

    • Incorporate detergents at appropriate concentrations

  • Implement signal amplification strategies:

    • Biotin-streptavidin systems

    • Tyramide signal amplification

    • Polymer-based detection systems

  • Consider adapter protocols for specific techniques:

    • Proximity ligation assays for increased specificity

    • Microfluidic-based detection platforms

How can yjgW antibodies be used to study protein evolution and functional diversity?

Based on findings in evolutionary biology research:

  • Develop antibodies specific to individual domains to track evolutionary changes

  • Compare domain-specific antibody reactivity across species to identify conservation patterns

  • Use antibodies to immunoprecipitate interacting partners of different domains

  • Apply antibodies to study expression patterns in different tissues and developmental stages

  • Investigate enzymatic activity using native PAGE with activity staining following immunoprecipitation

Research has demonstrated that chimeric proteins like yjgW can provide insights into how "protein functional diversity can expand rapidly under the joint forces of exon shuffling, gene duplication, and natural selection" .

How might computational approaches enhance yjgW antibody development and application?

Recent advances in computational biology offer powerful tools for antibody research:

  • In silico epitope prediction to identify optimal antigenic regions

  • Structure-based design for improved specificity and affinity

  • Molecular dynamics simulations to understand binding kinetics and stability

  • Machine learning approaches to optimize antibody properties

  • De novo antibody design targeting specific epitopes

Recent breakthrough research has demonstrated that "a fine-tuned RFdiffusion network is capable of designing de novo antibody variable heavy chains (VHH's) that bind user-specified epitopes" with structural confirmation through cryo-EM showing near-identical binding to the design model .

How can Open Science approaches improve reproducibility in yjgW antibody research?

The Open Science model demonstrated by initiatives like YCharOS addresses key challenges in antibody research:

  • Standardized characterization protocols enhance reproducibility across laboratories

  • Side-by-side testing of commercially available antibodies reduces resource waste

  • Collaborative efforts between academic and industry scientists improve antibody quality

  • Public access to validation data benefits the broader research community

  • Transparent methods documentation accelerates research progress

The YCharOS initiative has demonstrated successful collaboration between academic scientists and 11 major antibody manufacturers, representing approximately 80% of global renewable antibody production . This model provides a template for improving antibody research quality across fields.

How might yjgW antibodies contribute to understanding conserved protein domains across species?

Studies of conserved protein domains could benefit from yjgW antibody applications:

  • Investigation of functional conservation of the Adh-derived domain across species

  • Comparative analysis of post-translational modifications in homologous domains

  • Study of protein-protein interactions mediated by conserved domains

  • Examination of evolutionary constraints on key functional residues

  • Analysis of domain-specific expression patterns in different tissues

Research on influenza hemagglutinin has demonstrated how antibodies targeting conserved domains can provide insights into viral evolution and cross-protective immunity . Similar approaches could be applied to yjgW research.

What novel methodologies might improve yjgW antibody characterization in the future?

Emerging technologies with potential to advance antibody characterization include:

  • Single-molecule imaging techniques for real-time binding kinetics

  • Advanced mass spectrometry for epitope mapping and quantification

  • Microfluidic platforms for high-throughput antibody screening

  • CRISPR-based validation systems for confirming antibody specificity

  • Spatial transcriptomics combined with antibody-based protein detection

Recent advances in antibody characterization have demonstrated that combining multiple methodologies provides more comprehensive validation , suggesting integrated multi-modal approaches will be valuable for future research.

How can yjgW antibody binding kinetics inform functional studies?

Analysis of antibody binding kinetics can provide important insights into protein function:

  • Binding rate constants (kon/koff) may reflect conformational states of the target

  • Affinity measurements (KD) can identify high-affinity interaction sites

  • Temperature-dependent binding studies can reveal thermodynamic parameters

  • Competition binding assays can map functional domains

  • Differential binding in various buffers may indicate physiologically relevant states

For example, research on protective antibodies against viral proteins demonstrated that binding kinetics correlate with neutralization potency and protective efficacy in animal models .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.